Novavax Covid vaccine has potential to rival Pfizer, Moderna shots

Novavax Covid vaccine has potential to rival Pfizer, Moderna shots


A health worker prepares a dose of the⁣ Novavax vaccine as the Dutch Health ‍Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands.

Patrick Van Katwijk | Getty Images

Americans can finally get their hands on Novavax’s newest Covid vaccine after U.S. ‌regulators greenlighted the shot this week.

The vaccine’s arrival comes nearly three weeks after new jabs from Pfizer and Moderna ​reached the public, and after more than 4 million patients rolled up their sleeves ‌to get a shot ​in September. But Wall Street analysts aren’t worried about⁢ that delay.

They ‌said Novavax appears well positioned to catch up and compete‌ this fall with the other companies in the U.S. Covid vaccine market, particularly after logistical issues hampered the rollout of the other shots and a Food​ and Drug Administration label that allows for wide accessibility to Novavax’s jab, among other factors.

“I’m really not concerned about the timeline ⁣or​ lag relative to the…

2023-10-07 07:00:02
Post from www.cnbc.com

Exit mobile version